| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.75B | 55.73B | 55.88B | 50.22B | 44.79B | 43.07B |
| Gross Profit | 15.51B | 14.81B | 12.98B | 11.64B | 9.86B | 10.30B |
| EBITDA | 7.58B | 6.76B | 6.12B | 5.07B | 3.62B | 4.42B |
| Net Income | 4.23B | 3.96B | 3.29B | 2.54B | 1.89B | 2.31B |
Balance Sheet | ||||||
| Total Assets | 49.65B | 50.94B | 54.03B | 47.90B | 41.45B | 40.03B |
| Cash, Cash Equivalents and Short-Term Investments | 11.17B | 10.21B | 6.32B | 5.40B | 5.55B | 4.52B |
| Total Debt | 4.82B | 5.36B | 8.29B | 7.37B | 7.39B | 7.16B |
| Total Liabilities | 18.45B | 20.42B | 26.98B | 24.55B | 21.75B | 21.05B |
| Stockholders Equity | 26.53B | 25.63B | 22.25B | 19.07B | 17.60B | 16.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.67B | 680.79M | -697.79M | 2.00B | 4.44B |
| Operating Cash Flow | 0.00 | 8.94B | 1.15B | 120.19M | 3.17B | 5.10B |
| Investing Cash Flow | 0.00 | -1.02B | -330.72M | -1.73B | -2.07B | -505.09M |
| Financing Cash Flow | 0.00 | -3.36B | 76.30M | 15.76M | -100.30M | -3.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥87.86B | 15.43 | ― | 0.82% | 7.10% | 36.47% | |
76 Outperform | ¥271.07B | 22.86 | ― | 2.42% | 9.55% | 9.52% | |
74 Outperform | ¥11.56B | 9.21 | ― | 3.98% | 4.35% | 7.25% | |
73 Outperform | ¥2.68T | 23.15 | 8.35% | 1.77% | 5.39% | 4.89% | |
73 Outperform | ¥170.15B | 19.72 | ― | 1.39% | 11.23% | 16.49% | |
64 Neutral | ¥652.54B | 18.50 | ― | 2.14% | 7.73% | 30.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |